Trial intelligence / Profile preview

Preemptive etoricoxib for pain after third molar surgery

ChiCTR1900024503Phase 4Completed

Sponsor
Hospital of Stomatology, Wuhan University, Department of Oral and Maxillofacial Surgery
Start
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of etoricoxib in postoperative pain (3 arms), sponsored by Hospital of Stomatology, Wuhan University, Department of Oral and Maxillofacial Surgery. Primary endpoints: Pain intensity, Swallowing pain and 6 more. Started Aug 2019; status: completed.

02

Drugs

etoricoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR1900024503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900024503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call